Humanigen, Inc. (NASDAQ: HGEN) is a clinical-stage biopharmaceutical Company that is focused on creating a portfolio of monoclonal antibodies targeting immunology and immune-oncology disorders. The Company’s lead product candidate is lenzilumab, an anti-human granulocyte-macrophage colony-stimulating factor (“GM-CSF”) monoclonal antibody, formulated using the Company’s proprietary Humaneered®...
Biotech Companies continue to show resurgence even in these challenging times, with more and more companies persevering with bringing their clinical candidates to fruition. While Vaccine development and therapeutics to combat the COVID-19 pandemic are at the forefront of development activities in the biotech sector,...
Covid-19 has bought many biotech companies into the limelight, all promising a possible solution to the pandemic that has disrupted lives worldwide. In February 2021, Ocugen, Inc. (NASDAQ: OCGN) shares catapulted after news of the Company signing a binding letter of intent (LOI) with Bharat...
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is a clinical-stage biopharmaceutical company that is developing innovative precision medicine for debilitating musculoskeletal diseases. The Company is leveraging its knowledge and expertise in muscle biology, biophysics and small molecules to create a pipeline of candidates that address large unmet...
CytoKinetics, Inc. (NASDAQ: CYTK), a late-stage biopharmaceutical company, is developing therapeutics for the treatment of cardiovascular and neuromuscular diseases that are characterized by impaired muscle function such as amyotrophic lateral sclerosis (ALS), spinal muscular atrophy (SMA) heart failure and hypertrophic cardiomyopathies (HCM). The Company announced preclinical...
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is focused on developing innovative small molecule drugs that target hematologic disorders, cancer and rare immune diseases. The Company announced positive topline results from a phase 2 evaluation of fostamatinib, an oral spleen tyrosine kinase (SYK) inhibitor, intended for the...
Biotech Companies continue to show resurgence even in these challenging times, with more and more companies persevering with bringing their clinical candidates to fruition. While Vaccine development and therapeutics to combat the COVID-19 pandemic are at the forefront of development activities in the biotech sector,...
Ontrak Inc (NASDAQ: OTRK), a virtual provider of AI-powered Telehealth solutions announced the signing of an updated contract with Health Alliance Medical Plans that extends their partnership, which originally began in 2015, to offer uninterrupted access to critical behavioral healthcare for the Medicare and commercial...
MannKind Corporation (NASDAQ: MNKD) is a biopharmaceutical company that is leveraging its unique Technosphere Technology, to develop and commercialize inhaled therapeutics, for the treatment of endocrine and orphan lung diseases. The Company’s work is based on the foresight of the visionary inventor and Alfred E....
Biotech Companies continue to show resurgence even in these challenging times, with more and more companies persevering with bringing their clinical candidates to fruition. While Vaccine development and therapeutics to combat the COVID-19 pandemic are at the forefront of development activities in the biotech sector,...
